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Abstract: Considering the safety-risk ratio of steroidal contraceptives, the present 
work was carried out to evaluate ethno-contraceptive use of Cordia dichotoma G. 
Forst., Boraginaceae, leaves (LCD). Preliminary pharmacological screening was 
performed on post-coital female albino rats. The leaves extract (LD50 5.50 g/
kg bw) showed 100% anti-implantation activity (n=10) at 800 mg/kg dose level. 
(2-hydroxypropyl)-β-cyclodextrin (BCD) was used as bioavailability enhancer to 
form LCD-BCD complex, characterized by DLS, SEM and XRD analyses. The 
LCD-BCD complex (1:1, w/w) exhibited 100% pregnancy interception (n=20) at 
the dose level of 250 mg/kg and also showed strong estrogenic potential with a 
luteal phase defect. Qualitative and quantitative phytochemical analyses were 
carried out. The LCD extract was standardized by a validated HPTLC method and 
two contraceptive phytoconstituents, apigenin and luteolin were isolated. A detailed 
pharmacological analyses followed by chronic toxicity study were performed to 
predict the reversible nature of the developed phytopharmaceutical. The histological 
and biochemical estimations detected the reversible contraceptive potential after 
withdrawal. The observations suggested that the developed phyto-pharmaceutical 
has potential antifertility activity with safety aspects.
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Introduction
 Several adverse effects of steroidal 
contraceptives are observed, especially metabolic 
disorders and sex-characteristics after menopause 
(Tanis et al., 2001; Unny et al., 2003). In response to 
increasing drug development costs due to candidate 
safety and efficacy, one of the most challenging pursuits 
in the realm of pharmaceutical and medical sciences 
is the search for newer and more potent drugs with 
least toxic profile, self-administrable, less expensive 
and completely reversible (FDA, 2004). Plant drugs 
are generally considered as safe and cheap medicines, 
and interest in the pharmacological role of bioactive 
compound(s) present in plant is increased in last decade 
(Ulrich-Merzenich et al., 2009). The various reviews 
reported on medicinal plants and their active principles 
for fertility regulation (Unny et al., 2003).
 Systemic standardization of ethno-medicinal 
herbal formulation into modern phytopharmaceutical 
provided the chance of increased efficacy and safety 
profile of traditional medicine. Additionally for achieving 
target bioavailability a certain degree of lipophilicity 
is prerequisite for a drug candidate. Inclusion with 
a carrier increases the absorption rate of the active 
pharmaceutical ingredient, which in turn can lead to 
substantial increase in oral bioavailability (Kesisoglou 
et al., 2007). Application of (2-hydroxypropyl)-β-
cyclodextrin (BCD) in oral drug delivery is presently 
incorporated in various pharmacopoeias and national 
formularies (Loftsson & Brewster, 1996; Challa et 
al., 2005). The effects of BCD on p-glycoprotein and 
cytochrome P450 facilitated oral absorption (Ishikawa 
et al., 2005; Fenyvesi et al., 2008).
 In the present work, a detailed post-coital 
female contraceptive assessment in rats was carried 
out after standardizing the leave extract of Cordia 
dichotoma G. Forst., Boraginaceae (LCD). Usage of the 
herb for its antifertility potency is documented (Anjaria 
et al., 2002; Bhattacharya, 2006). The anti-implantation 
activity of the bark of C. dichotoma is reported 
(Katolkar et al., 2012). The leaves of C. curassavica 
and C. spinescens were also used to cure menstrual 
pain and relieve postpartum pain respectively (Lans, 
2007). Presence of diverse type of phyto-constituents, 
mono and poly saccharides, β-sitosterol, allantoin and 
flavonol glycosides of taxifolin, distylin and apigenin 
had been reported in these species (Samant & Pant, 
2006; Ganjare et al., 2011).
 The complex of standardized extract preparation 
and bioavailability enhancer was characterized, and 
the reversibility and toxicity profi le of the developed 
preparation were analysed by chronic toxicity studies. 
Article
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Material and Methods
Extract preparation
 Leaves of Cordia dichotoma G. Forst., 
Boraginaceae, were collected from Acharya Jagadish 
Chandra Bose Indian Botanic Garden, West Bengal, in 
the month of March and identified by the Central National 
Herbarium, Botanical Survey of India. A voucher specimen 
was stored in department for future reference. The cleaned 
leaves were shade dried and subsequently powdered. The 
powder material was extracted with 40% ethanol (1:8 w/v) 
by continuous hot percolation in a Soxhlet extractor. The 
extract solution was washed with n-hexane, filtered and 
subsequently vacuum dried. The material had an extractive 
value of 15.8% (w/w). The powders were dispersed in 
distilled water prior to administration.
Detection of toxic metal elements
 An atomic absorption spectroscopic study of 
LCD extract was carried out for detection of toxic metals. 
LCD powder was burnt into flame for 30 min. The 
resultant ash was poured in hydrochloric and nitric acid 
mixture (3:1), sonicated and filtered. Standard samples 
of arsenic, cadmium and lead were used as markers in 
concentration ranging 5 to 200 ppb diluted in HPLC water, 
and measurements were performed (Mitra et al., 2002).
Animals
 Female Swiss albino mice (20 g) and albino 
Wister female rats (180-200 g) were used for acute and 
chronic toxicities screening respectively. Colony-bred 
adult male and female (140-220 g) rats were used for 
antifertility testing, white immature female (40-60 g) 
rats used for the estrogenic assessment. All the biological 
including animal experiments were performed after 
approval and according to the protocol of the Institutional 
Animal Ethics Committee (Reg. No.: 506/01/a/CPC 
SEA).
Acute toxicity studies and LD50 assessment
 For acute toxicity study, LCD extract was 
administered orally at single doses of 0.5, 1, 2, 3, 3.5, 4, 
4.5, 5, 5.5 and 6 g/kg bw to individual group. General 
behaviors were monitored with control group. The 
toxicological effect was assessed on the basis of mortality 
after 24 h. The percentage of mortality was converted to 
probits and the values are plotted against log dose. The 
LD50 was the dose intersected by probit 5 (Veerappan et 
al., 2007).
Screening of female rats for antifertility testing
 The estrus cycle of rats was monitored for 14 
days. Acyclic rats and rats with prolonged cycles were 
screened and eliminated. The process includes examination 
of vaginal smear to observe different phases and duration 
of estrus cycle (Marcondes et al., 2002).
Selection of dose
 In contraceptive applications, Indian traditional 
documentation reported that 2-3 standard sized leaves 
of C. dichotoma are fried with rice and taken for 2-3 
days per week (Bhattacharya, 2006). Four dose levels 
(i.e. 1000, 800, 400, and 200 mg/kg/day) were selected 
for contraceptive profile screening. Drugs were orally 
administered in post-coital female rats from day 1-7 of 
pregnancy. 
Evaluation of post-coital pregnancy interceptive activity
 The pharmacological assessment for post-coital 
contraceptive profile has been performed (Pattanayak & 
Mazumder, 2009). The animals were laparotomised under 
light ether anesthesia and aseptic conditions on day 10 of 
pregnancy. Both horns of the uterus were observed for the 
number and status of implants. The ovary was carefully 
observed and the number of corpora lutea was counted. 
The rats were allowed to recover and deliver after full term. 
The litters were allowed to grow to check their postnatal 
growth and monitor any congenital abnormalities up to 
7 days post partum period. Rats that did not deliver had 
laparotomised on day 25 and their uteri were observed to 
reveal any evidence of implantation. LCD extract showed 
prominent action in pharmacological screening. Different 
dose levels of LCD-BCD complex were administered in 
post-coital female albino rats. The dose level exhibiting best 
activity profiles was subjected for detailed pharmacological 
assessments.
Characterization of developed formulation
 (2-Hydroxypropyl)-β-cyclodextrin (BCD) was 
used as bioavailability enhancer. Inclusion complex of 
LCD-BCD (1:1, w/w) formulation was prepared by co-
evaporation technique (Shahgaldian et al., 2003). BCD 
solution in water was mixed with LCD in 40% ethanol 
at room temperature. Excess solvent was evacuated from 
the complex using rotary evaporator at 70 oC. The semi-
dried product was lyophilized, powdered and stored in a 
desiccator at room temperature. Powders were dispersed 
in distilled water prior to administration. Particle size 
distribution of the powder in water was measured by 
dynamic light scattering (DLS). The mean hydrodynamic 
(peak) and size distribution (width) of the preparation were 
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assessed by Zetasizer 2000 (Malvern, UK). The surface 
structure of the particles was visualized by scanning 
electron microscopy (SEM) (Hitachi VP-SEM S-3400N). 
Samples were gold sputtered in a sputter coater (Hitachi, 
E-1010) for 40 s and scanning was performed at 15 kV with 
40,000 magnifications. X-ray diffraction (XRD) of BCD, 
LCD and LCD-BCD were recorded with a XPERT-PRO 
X-ray diffractometer (Model: PW 3050/60, PANalytical, 
Almelo, Netherlands). The 2θ range is 5-600 and the scan 
rate is 10/min with Cu Kα radiation (40 kV, 30 mA). 
Determination of estrogenic/antiestrogenic property
 Ovariectomy was performed in immature female 
albino rats (Zarrow et al., 1964). After one week of the 
operation, animals were divided into four groups. The 
first group served as control and received the vehicle only 
(aqueous BCD solution). The second group received a 
suspension of estradiol valerate in distilled water containing 
dimethyl sulphoxide (10%, v/v) at a dose of 1 mg/kg body 
weight. The third group received the test dose (LCD-
BCD) and the fourth group received a combination of test 
(LCD-BCD) and standard doses. All the treatments were 
given orally for seven days. On 24 h after the last dose, 
the animals were weighed, vaginal openings and vaginal 
smears were observed and sacrificed by cervical dislocation 
under light ether anesthesia. The uterine horns were 
removed, trimmed, opened longitudinally, blotted between 
cold and wet tissue papers and weighed immediately. The 
uterus was homogenized with cold normal saline solution 
containing 10 mg of tissue/mL. The homogenate was cold 
centrifuged at 900 x g for 15 min and the supernatant was 
used for the estimation of glucose, cholesterol and alkaline 
phosphatase (Pattanayak & Mazumder, 2009).
Determining variations in estrous cycles, blood biochemical 
parameters and histology of ovary and uterus
 LCD-BCD was administered on 1-7 d of 
pregnancy. Before and after treatment, 2 mL of blood 
was drawn from orbital plexus. Serum gonadal hormones 
(estradiol, progesterone, DHEA-S, testosterone and 
cortisol), gonadotrophic hormones (FSH and LH), 
lipid-carbohydrate profiles (cholesterol (TC), HDL-C, 
triacylglyceride, VLDL-C, LDL-C and glucose), marker 
of lipid peroxidation (malondialdehyde) and serum 
antioxidant levels (glutathione and nitric oxide) were 
estimated. 
Test of reversibility of anti-fertility effect and chronic 
toxicity studies
 Adult female rats were acclimatized for a period 
of one month. During the period normal behavioral 
parameters like food intake, body weight gain and stool 
quality were checked. Normal cyclic rats (n=24) were 
divided into two groups (n=12) and were treated with 
LCD-BCD complex or vehicle for 21 days, and kept in 
normal condition for further 21 days. 
 The animals of each group were further divided 
into two groups. For the first group of each (n=6), the 
estrus cycles were monitored and animals in pro-estrus 
phase were allowed to mate with male. After completion 
of one gestation period, number of litters, average wt of 
pups on day 7 and viability index were checked. 
The animals of other group were sacrificed, blood collected 
via cardiac puncture, and the liver, kidneys and lungs 
were taken for histological analysis. Serum biochemical 
parameters, SGPT and SGOT, ALP, creatinine and uric 
acid, MDA, GSH and NO were estimated.
Isolation of bioactive constituents and standardization of 
the extract
 LCD was screened for presence of phenolic 
contents, flavonoids, tannins, essential oils, alkaloids, 
tannins, saponins, glycosides, steroids and terpenes by 
different qualitative chemical analyses (Harborne, 1998). 
LCD (10 g) was treated with 2N HCl for 1 h at 100 oC. 
The cooled solution was saturated with sodium chloride, 
partitioned with ethyl acetate and dried under nitrogen 
atmosphere. The dried residue was dissolved in ethanol 
and separation was performed in preparative TLC method 
developed in our laboratory. Silica gel (0.3 mm thickness) 
was used as stationary phase and toluene-ethyl acetate-
methanol mixture (5:4.5:0.5) as mobile phase. After 
development of chromatogram, the separated spots were 
visualized by UV light at 254 nm and the major components 
are recovered by treating each portion of adsorbent 
with methanol. After separation, 10 mg of compound 
A and 23 mg of compound B were isolated. Preliminary 
identification of these two compounds was carried out by 
Forestal chromatogram and melting point analysis. The 
spectral analyses (mass and nuclear magnetic resonance 
spectroscopy) of compounds A and B were carried out for 
identification. 
 Quantification of A and B in LCD was carried 
out by HPTLC analysis. Definite volumes of ethyl acetate 
fractions were applied on TLC plate. Densitometric 
scanning was performed at 254 nm. The linearity, precision, 
repeatability, accuracy, robustness, limit of detection 
(LOD) and limit of quantification (LOQ) were estimated for 
validation of the developed analytical method. Instrumental 
precision and repeatability of the method were checked by 
repeated scanning (n=6) of the same spots, expressed as 
relative standard deviation (% RSD). Variability of the 
method was studied by analyzing aliquots of standard 
solution on same day (intra-day precision) and other days 
(inter-day precision), and the results were expressed as 
% RSD. LOD and LOQ were determined at signal/noise 
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ratio of 3:1 and 10:1 respectively. The accuracy of the 
method was assessed by performing recovery study by 
addition of 50 and 100% of standard and expressed as 
average percent recovery. Robustness of the developed 
method was assessed after deliberate alterations of any 
one of experimental parameter. The plates were prewashed 
by methanol and activated at 110 oC for 2, 5, and 7 min 
respectively, prior to chromatography. Time from spotting 
to chromatography and from chromatography to scanning 
was varied by ±10 min. Development distance was altered 
from 7 to 6 cm and 8 cm. Time of hydrolysis was altered 
from 1 h to 50 and 70 min. Robustness of the method was 
carried out at the concentration level of 200 ng/spot in 
triplicate.
Results and discussion
AAS analysis of heavy metal in LCD
 The minerals responsible for irreversible 
toxicities of reproductive organs were found in different 
parts of herbs grow in polluted soil due to industrial and 
anthropogenic activities (Wang et al., 1996). The contents 
of arsenic (Chattopadhyay et al., 1999), cadmium (Johnson 
et al., 2003) and lead (WHO, 1995) in LCD preparation 
were found to be lower than the permissible limits (<5 
ppb) mentioned in US-FDA and AYUSH (Sahoo et al., 
2010).
Acute toxicity study
 Except reduced locomotion (hypoactivity) in 
the dose equal to or lower than 3.5 g/kg bw, no signs of 
toxicity were observed in rats treated with a single dose 
of LCD extract. At higher doses, a regular dose-dependent 
increase in mortality was observed. The oral LD50 of LCD 
was found to be 5.50 g/kg (data not shown).
Phytochemical characterization
 Qualitative chemical examinations of LCD 
extract exhibited prominent presence of flavonoids, 
tannins, terpenoids and glycosides, with traces of 
alkaloids and saponins. Two flavonoid aglycones, A and 
B were isolated and characterized.
 Compound A: Pale yellow powder; mp 340-343 
oC; bluish black coloration with aqueous ferric chloride; 
TLC on cellulose plate, Rf 0.8 (pale brown spot on Forestal 
chromatogram, black in ammonia vapor); UV (MeOH) 
λmax 268, 306, 327 nm; 
1H NMR (CD3OD and DMSO-d6 
(4:1, v/v), 500 MHz) δ 12.95 (1H, s, OH-5), 10.82 (1H, 
s, OH-7), 10.34 (1H, s, OH-4’), 7.92 (2H, d, J=8.77 Hz, 
H-2’, H-6’), 6.91 (2H, d, J=8.77 Hz, H-3’, H-5’), 6.77 (1H, 
s, H-3), 6.47 (1H, d, J=2.00 Hz, H-8), 6.18 (1H, d, J=1.99 
Hz, H-6); 13C NMR (DMSO-d6, 125 MHz) δ 181.8 (C-4), 
164.2 (C-2), 163.6 (C-7), 161.1 (C-5 and C-4′), 157.1 
(C-9), 128.2 (C-2′ and C-6′), 120.4 (C-1′), 115.9 (C-3′ and 
C-5′), 103.8 (C-10), 102.4 (C-3), 99.1 (C-6), 94.3 (C-8); 
HREIMS m/z 271.0602 (calcd for C15H10O5, 271.0625), 
confirmed apigenin (AP) (Harborne, 1998).
 Compound B: Yellow powder; mp 326-328 oC; 
bluish black coloration with aqueous ferric chloride; TLC 
on cellulose plate, Rf 0.65 (pale brown spot on Forestal 
chromatogram, black in ammonia vapor); UV (MeOH) 
λmax 253, 268, 306, 339 nm; 
1H NMR (CD3OD and DMSO-
d6 (4:1, v/v), 500 MHz) δ 12.96 (1H, s, OH-5), 7.38-7.41 
(2H, m, H-2’, H-6’), 6.88 (1H, d, J=8.30 Hz, H-5’), 6.66 
(1H, s, H-3’), 6.43 (1H, d, J=2.07 Hz, H-8), 6.18 (1H, d, 
J=2.06 Hz, H-6); 13C NMR (DMSO-d6, 125 MHz) δ 182.4 
(C-4), 164.2 (C-2), 163.8 (C-7), 160.2 (C-5), 158.6 (C-9), 
148.6 (C-4′), 146.2 (C-3′), 122.4 (C-1′), 119.2 (C-6′), 114.3 
(C-5′), 112.3 (C-2′), 103.4 (C-10), 102.3 (C-3), 98.3 (C-6), 
94.2 (C-8); HREIMS m/z 309.0375 (calcd for C15H10O6 Na, 
309.0375) indicated presence of luteolin (LT) (Harborne, 
1998).
Standardization of LCD extract
 HPTLC method validation parameters, inter and 
intra-day precisions and recovery studies were performed 
(Table 1). Different sample solutions and solvent systems 
were tried in order to resolve the marker compounds. 
The developed TLC densitometric method was validated 
in terms of precision, repeatability and accuracy. The 
linearity range for AP and LT was found to be 50-200 ng/
spot, with correlation coefficient >0.99 in both the cases. 
The method was found to be precised with % RSD (n=3) 
for intra-day in the range of 0.98-1.15 and 0.91-0.96, and 
for inter-day in the range of 1.13-1.28 and 1.01-1.22 for 
50 and 200 ng of AP and LT respectively, indicating the 
proposed method was accurate and reproducible. The 
LOD and LOQ values for both were found to be 10 and 
40 ng respectively. The average recoveries at two different 
levels of AP and LT were found to be 99.24 and 99.87% 
respectively. Robustness of the method was checked after 
deliberate alterations of the analytical parameters, showed 
that areas of peaks of interest remained unaffected by 
small changes of the operational parameters. Less than 2% 
of RSD along with appreciable recovery are indicative of 
the robustness of the method. AP and LT were quantified 
in LCD sample and are found to be 0.14 and 0.32% (w/w) 
with Rf of 0.70 and 0.65 respectively.
Pharmacological screening
 It was observed that LCD revealed anti-
implantation potential in a dose-dependent manner (Table 
2). The test substance, LCD when administered at 1000 
mg/kg (T4), no implantation sites were observed but 
caused behavioral changes. The observable symptoms 
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included reduced food intake and general weakness that 
revealed through slow and crippled movements. The 800 
mg/kg dose of LCD (T3) also resulted in 100% pregnancy 
interception without any behavioral changes (n=10). It 
executed the contraceptive potency in a relatively higher 
dose level. Thus incorporation of bioavailability enhancer 
in the extract formulation was considered.
Characterization and pharmacological evaluation of 
developed formulation
 The mean particle size of the LCD-BCD 
formulation, analyzed by DLS, was found to be 174.7 
nm with a poly-dispersity index of 0.281 (Figure 1A). 
Spherical non-adherent particles were observed upto one 
month of preparation indicated stability of the formulation 
(Figure 1B). The interaction of drug with polymer was 
clearly visible in XRD patterns (Figure 1C). In the product 
(Figure 1C, b), the intensity of BCD at 18.770 contrast to 
the intensity at 16.860 was thirteen times amplifi ed, implied 
some change in BCD matrix mixture. The diffraction peak 
of LCD powder revealed several sharp peaks at diffraction 
angles (2θ) of 19.350, 21.420, 22.360, 25.830, 28.370 and 
40.510. These peaks were mostly absent in LCD-BCD 
complex indicates formation of amorphous state and 
complexation. Reduction in crystalline nature obviously 
pretends a role for better oral bioavailability.
 LCD-BCD formulation exhibited 100% anti-
implantation activity in all 800, 500 and 250 mg/kg dose 
levels (Table 2). LCD-BCD at 250 mg/kg dose (T7) was 
found to be selective among all the treatments for post-
coital antifertility testing (n=20), hence considered for 
detailed pharmacological investigations.
Figure 1. Characterization of LCD-BCD complex. A. Size 
distribution in DLS; B. Surface structure by SEM and C. Drug-
polymer interaction observed in XRD pattern, aBCD, bLCD-BCD 
complex, cLCD.
Pharmacological fi ndings
 Effect in ovariectomised rats (OVX) 
 T7 caused a signifi cant increase in uterine weight 
(193.8%) in OVX as compared to control (Table 3). The 
Table 1. Validation of TLC densitometric method for quantifi cation of apigenin (AP) and luteolin (LT).
Recovery study
Marker Present (ng) Added (ng) Recover (ng) Recovery (%)a Averagerecovery (%)
AP 70 35 105.11±3.24 100.10±3.08
99.24
70 70 137.72±0.84 98.37±0.60
LT 160 80 236.49±2.13 98.54±0.89
99.87
160 160 323.85±2.30 101.20±0.72
Intra-day
and inter-day 
precision
Marker Concentration (ng) Intra-day precisiona Inter-day precisiona
AP
50 0.98 1.13
200 1.15 1.28
LT
50 0.96 1.01
200 0.91 1.22
Instrumental precision (AP and LT)b 1.18, 1.24
Repeatability (AP and LT)b 0.88, 1.02
LOD (ng) 10
LOQ (ng) 40
Specifi city Specifi c
Linearity (correlation coeffi cient) for AP and LT 0.99999, 0.99976
Range (ng spot-1) 50-200
SD (%) for AP and LT 0.30, 1.90
a% RSD, n=3; b% RSD, n=6.
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uteri were fluid filled. T7 induced vaginal opening in OVX 
and the smear showed a condition of estrous or proestrous, 
while the control rats had closed vaginas. A significant 
increase of glucose (54.35%), cholesterol (20.57%) and 
alkaline phosphatase (30%) were observed in uterine tissue 
homogenates. Co-administration of EV with LCD–BCD 
formulation caused a significant increase in uterine weight 
(240.2%) in OVX, but the extent of uterotropic effect was 
considerably less than that produced by EV alone (Table 3). 
Thus LCD revealed estrogenic activity when administered 
alone, but exhibited impeded estrogenic activity when 
administered with estrogen.
Serum hormonal and biochemical profiles
 Figure 2 depicts the results of biochemical assay. 
There was diminution in serum progesterone (13.90%), 
and increment in estradiol (14.51%) and DHEA-S 
(46.93%) contents. In case of gonadotrophin hormone, 
FSH was observed to be significantly decreased (106.67%) 
with a slight reduction in LH levels, i.e. LH-FSH ratio 
alters. Body weight had been found to be 3.14% elevated 
after seven days treatment period. It indicated that drug 
administration significantly influenced corpus luteum 
function by affecting steroid biosynthesis. Probably the 
remarkable increase in serum estradiol levels caused a 
reduction in the functional life-span of the corpus luteum 
(Williams & Lemke, 2002).
 A relation between ovarian estrogen production 
and adrenal androgen synthesis had also been evaluated. 
Elevated levels of estrogen could have a direct adrenal 
effect (Steinmetz et al., 1997). A stress condition might 
be generated upon treatment with LCD-BCD. Cortisol 
(15.18%) and malondialdehyde (MDA, 11.33%) levels 
were raised, while GSH level fall down (5.23%) with 
increased adrenal DHEA-S output (46.93%) (Figure 2). 
Table 2. Contraceptive property assessment.
Group Test substance
Oral dose 
(LCD, mg/kg) n nP PI nCL nI nL nLD* mLW VI(%)*
C Vehicle - 6 6 - 9.3±0.3 8.7±0.2 8.3±0.2 0.0±0.0 15.4±0.1 100±0.0
T1 LCD 200 6 5 16.7 5.7±0.2 3.8±0.8 3.6±0.2 0.6±0.4 15.1±0.1 80.0±13.3
T2 LCD 400 6 3 50 5.5±0.2 1.3±0.6 2.0±0.0 1.3±0.7 15.2±0.0 33.3±33.3
T3 LCD 800 10 0 100 4.8±0.3 0.0±0.0 - - - -
T4 LCD 1000 6 0 100 5.2±0.3 0.0±0.0 - - - -
C1 BCD - 5 0 100 9.0±0.3 8.6±0.2 8.2±0.2 0.0±0.0 15.9±0.1 100±0.0
T5 LCD-BCD 800 6 0 100 4.3±0.2 0.0±0.0 - - - -
T6 LCD-BCD 500 6 0 100 4.3±0.2 0.0±0.0 - - - -
T7 LCD-BCD 250 20 0 100 4.8±0.2 0.0±0.0 - - - -
T8 LCD-BCD 100 6 4 33.3 4.5±0.2 2.0±0.7 0.5±0.3 0.5±0.5 13.9±0.0 50.0±50.0
n, nP, PI, nCL, nI, nL, nLD, mLW and VI represent the number of animals in a group, number of pregnant animals, percentage pregnancy interception, 
number of corpora lutea, number of implantation sites, number of litters born on parturition, number of litters that died within 7 d of parturition, mean 
live litter weight on day 7 and viability index respectively. The results are presented as mean±S.E. One way analyses of variances, nCL: F=36.72 
(df=9,67), nI: F=106.39 (df=9,67), nL: F=244.55 (df=4,18), nLD: F=2.88 (df=4,16), mLW: F=10.75 (df=4,13) and  VI: F=3.34 (df=4,16). The values 
are significant at p<0.005 except *p>0.03.
Table 3. Evaluation of estrogenic and anti-estrogenic profiles.
Dose 
(mg/kg, bw)
NOV 
(%)
NC 
(%)
Uterine weight 
(mg/100g, bw)
Biochemical changes in uterus
Glucose 
(mg/100 g)
Cholesterol 
(mg/100 g)
ALP 
(IU/100 g)
Control 0 0 61.2±0.5 (n=16)
0.92±0.01 
(n=10)
5.30±0.04 
(n=10)
0.50±0.01 
(n=10)
EV (1) 100 100 217.6±1.8 (n=17)
1.71±0.01 
(n=11)
7.43±0.03 
(n=11)
0.89±0.01 
(n=11)
LCD-BCD 
(250) 47 35
179.8±1.5 
(n=15)
1.42±0.01 
(n=9)
6.39±0.03 
(n=9)
0.65±0.01 
(n=9)
EV (1) + LCD-
BCD (250) 80 60
208.2±1.0 
(n=10)
1.64±0.01 
(n=8)
6.91±0.04 
(n=8)
0.84±0.01 
(n=8)
NOV is the number of animals with open vagina; NC represents number of animals with predominantly cornified cells like estrus stage. The results 
are presented as mean±S.E. One way analysis of variance, uterine weight: F=2746 (df=3,54); uterine glucose: F=2140 (df=3,34); uterine cholesterol: 
F=651 (df=3,34) and uterine ALP: F=961 (df=3,34). The values are significant at p<0.01.
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Estrogen increased the cortisol-binding globulin and the 
free cortisol level elevated. Estrogen also decreased the 
ability of liver to metabolize cortisol and contributed to 
the elevation of unbound cortisol (Speroff et al., 1999). 
Paradoxically, a diminished level of testosterone (20.76%) 
was also found, due to binding with serum proteins that 
might be induced with use of contraceptives (Palatsi et al., 
1984). Explanation can also be drawn from enhanced level 
of DHEA-S. Testosterone was produced from DHEA. The 
dosage form of LCD might be interrupting the pathway 
of conversion. Some antiandrogenic terpenoids were 
isolated from Cordia multispicata of Boraginaceae family 
(Kuroyanagi et al., 2001). Terpenoidal components present 
in LCD might be responsible for this kind of effects.
Figure 2. Effects of LCD-BCD formulation on biochemical 
profi les. B.T.: before treatment, A.T.: after treatment; 1estradiol 
(pg/mL), 2progesterone (ng/mL), 3DHEA (ng/mL), 4testosterone 
(ng/10 mL), 5FSH (mIU/dL), 6LH (mIU/dL), 7glucose (mg/
dL), 8cholesterol (mg/dL), 9triacylglyceride (mg/dL), 10HDL-
cholesterol (mg/L), 11VLDL-cholesterol (mg/L), 12LDL-
cholesterol (mg/dL), 13cortisol (ng/mL), 14MDA (μg/10 mL), 
15GSH (μg/mL), 16NO (μg/dL), 17Body weight (g). The changes 
with respect to B.T. are signifi cant at p<0.01, except *p<0.05 and 
∆p>0.1.   
 From Figure 2, it can be ascertained that a 
signifi cant decrease in blood glucose (22.12%), possibly 
disrupts oxidative energy metabolism in uterus during 
implantation, providing environment unreceptive for 
implantation (Keshri et al., 2004). Although LCD-BCD 
did not promise any benefi cial serum antioxidant status, 
a signifi cant decline in blood cholesterol (11.71%), 
VLDL-C (16.28%), triacylglyceride (16.26%) and LDL-C 
(16.26%), and increase in HDL-C (18.27%) confi rmed 
that LCD has favorable effect on lipid profi le and seems to 
be free of cardiovascular risk factors, unlike steroidal oral 
contraceptives (Wahl et al., 1983).
Relation with marker compounds 
 AP and LT, isolated from Boraginaceae family, 
have signifi cant contraceptive property (Hiremath et 
al., 2000), individually at dose level of 25 mg/kg. In 
the developed dosage form, these two compounds were 
cumulatively administered at a level of approximately 1.25 
mg/kg (0.5% of 250 mg/kg dose, T7) and exhibited 100% 
contraceptive potential (Table 2). These two components 
showed weak estrogenic actions, when administered alone 
(Hiremath et al., 2000). But LCD-BCD exerted strong 
estrogenic potential (Table 3). Herbal medicines consist 
of the active compound(s) along with other ingredients. 
The results of the activation of a signal cascade can be 
due to signal amplifi cation, and is much greater than the 
summation of the single effects (Imming et al., 2006; 
Wagner & Ulrich-Merzenich, 2009). Both the compounds 
might have super-additive agonistic effect to each other 
that possibly imported estrogenic contraceptive property.
Chronic toxicity studies
 The various parameters were assessed to estimate 
chronic toxicity of LCD-BCD. Comparable number of 
litters born with 100% viability index indicated reversible 
contraceptive nature of LCD. The morphological and 
histological examinations (Figure 3) showed that no 
toxic sign of organ damage in the test group, and results 
were comparable with control. The levels of liver marker 
enzymes, SGPT, SGOT and ALP were normal. Renal 
function parameters, marker of lipid peroxidation and 
antioxidant status were also unaltered and did not show 
any toxic pitfall (Table 4).
Figure 3. Comparative histological changes. Liver: A. Control; 
B. Treated. Kidney: C. Control; D. Treated. Lungs: E. Control; 
F. Treated.
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Conclusion
 The developed formulation of standardized 
Cordia dichotoma leaf extract showed potent 
contraceptive potential. It has strong estrogenic potential 
but lack of major cardiovascular risks associated with 
estrogens, even after long term of administration.
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